Human Reproduction, Vol. 10, No. 2, pp. 293-298, 1995
© 1995 European Society of Human Reproduction and Embryology
research-article |
Endocrinology: A prospective randomized single-blind comparative trial of nafarelin acetate with buserelin in long-protocol gonadotrophin-releasing hormone analogue controlled in-vitro fertilization cycles
Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital Oxford OX3 9DU, UK
The use of gonadotrophin-releasing hormone (GnRH) agonists to control ovulation induction cycles for in-vitro fertilization (IVF) has been shown to increase the pregnancy rate and live birth rate compared with non-analogue cycles. Different formulations of GnRH agonist are available with different routes and frequencies of administration. In this prospective study, the efficacy and safety of intranasal nafarelin and buserelin as adjunctive therapy during IVF were assessed. A total of 240 female patients were recruited to the study and in the first phase patients were randomized to receive either intranasal nafarelin 200 µg twice daily or buserelin 200 µg five times daily. In the second phase, patients received either nafarelin 400 µg twice daily or buserelin 200 µg five times daily. Nafarelin 400 µg and buserelin 200 µg both produced clinical pregnancy rates of 31% per recruit and 39% per embryo transfer. The rates for nafarelin 200 ug were 23 and 37% respectively. There was no statistically significant difference in pregnancy rates, by either drug or dosage. The time taken for pituitary down-regulation to be achieved was significantly longer on nafarelin 200 µg than on either nafarelin 400 µg or buserelin. The total number of days stimulation with human menopausal gonadotrophin required to reach criteria for human chorionic gonadotrophin (HCG) administration was significantly longer on buserelin than on either dose of nafarelin. Median serum oestradiol concentrations on the day of HCG administration were significantly higher on either dose of nafarelin than on buserelin.
Key words: buserelin acetate/GnRH analogues/in-vitro fertilization/nafarelin acetate/ovulation induction
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Fleming Progesterone elevation on the day of hCG: methodological issues Hum. Reprod. Update, June 2, 2008; (2008) dmn019v1. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bjercke, P. Fedorcsak, T. Abyholm, R. Storeng, G. Ertzeid, N. Oldereid, A. Omland, and T. Tanbo IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression Hum. Reprod., September 1, 2005; 20(9): 2441 - 2447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Almagor and Y. Hovav The development of an oocyte-containing follicle during gonadotrophin-releasing hormone agonist administration Hum. Reprod., August 1, 2001; 16(8): 1698 - 1699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Dor, D. Bider, A. Shulman, J. Levron, S. Shine, S. Mashiach, and J. Rabinovici Effects of gonadotrophin-releasing hormone agonists on human ovarian steroid secretion in vivo and in vitro--results of a prospective, randomized in-vitro fertilization study Hum. Reprod., June 1, 2000; 15(6): 1225 - 1230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Al-Azemi, A. L. Bernal, J. Steele, I. Gramsbergen, D. Barlow, and S. Kennedy Ovarian response to repeated controlled stimulation in in-vitro fertilization cycles in patients with ovarian endometriosis Hum. Reprod., January 1, 2000; 15(1): 72 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lashen, W. Ledger, A. Lopez-Bernal, and D. Barlow Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile? Hum. Reprod., April 1, 1999; 14(4): 964 - 969. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lashen, W. Ledger, A. L. Bernal, and D. Barlow Extremes of body mass do not adversely affect the outcome of superovulation and in-vitro fertilization Hum. Reprod., March 1, 1999; 14(3): 712 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Dada, O. Salha, H.S. Baillie, and V. Sharma A comparison of three gonadotrophin-releasing hormone analogues in an in-vitro fertilization programme: a prospective randomized study Hum. Reprod., February 1, 1999; 14(2): 288 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Dancoine, G. Couplet, J. Buvat, C. Guittard, G. Marcolin, and J.-C. Fourlinnie Analytical and clinical evaluation of the Immulite(R) estradiol assay in serum from patients undergoing in vitro fertilization: estradiol increase in mature follicles Clin. Chem., July 1, 1997; 43(7): 1165 - 1171. [Abstract] [Full Text] [PDF]
|
|